Engineered biocatalysts and methods for synthesizing chiral amines
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Feb 27, 2018
Issued Date -
N/A
app pub date -
Dec 16, 2013
filing date -
Dec 21, 2012
priority date (Note) -
In Force
status (Latency Note)
Importance
Loading Importance Indicators... 
Abstract
The present disclosure provides engineered transaminase polypeptides for the production of amines, polynucleotides encoding the engineered transaminases, host cells capable of expressing the engineered transaminases, and methods of using the engineered transaminases to prepare compounds useful in the production of active pharmaceutical agents.
First Claim
Other Claims data not available
Family
Loading Family data...
International Classification(s)
- 2013 Application Filing Year
- C12P Class
- 1593 Applications Filed
- 1388 Patents Issued To-Date
- 87.14 % Issued To-Date
Cited Art Landscape
Patent Citation Ranking
- 2 Citation Count
- C12P Class
- 56.21 % this patent is cited more than
- 7 Age
Maintenance Fees
| Fee | Large entity fee | small entity fee | micro entity fee | due date |
|---|---|---|---|---|
| 7.5 Year Payment | $3600.00 | $1800.00 | $900.00 | Aug 27, 2025 |
| 11.5 Year Payment | $7400.00 | $3700.00 | $1850.00 | Aug 27, 2029 |
